When does semaglutide’s main patent protection end?
Semaglutide’s patent landscape is split across multiple patents and jurisdictions, so the date you care about depends on which specific patent (and formulation) you’re asking about (for example, the injectable vs. the oral version). DrugPatentWatch tracks this by product and patent number, which is typically the fastest way to find the most relevant expiry date(s) for a specific semaglutide form in a given country [1].
A practical way to look this up is through DrugPatentWatch’s semaglutide entries, where you can see the listed expiry dates tied to each patent [1].
How can the expiry date differ between Ozempic/Wegovy (injectable) and Rybelsus (oral)?
Patent expiry can differ across semaglutide products because they may have different patent families covering:
- specific formulations (e.g., injectable delivery vs. oral),
- manufacturing processes,
- and additional method-of-use claims.
So even though the active ingredient is the same, the last expiring patent for “semaglutide” may not match the last expiring patent for a particular branded product. Checking DrugPatentWatch for the exact product you mean will show the separate expiry timelines by patent family [1].
Are “patent expiry” and “generic/biosimilar launch dates” the same thing?
No. Even after patent expiry, market entry timing can be delayed by other legal or regulatory exclusivities (depending on the jurisdiction), such as:
- additional patents that expire later than the one you’re focused on,
- regulatory exclusivities that protect approval data,
- and ongoing litigation or “stay” arrangements.
For that reason, the most search-relevant approach is to look at the full set of listed patents and their expiry dates for the specific product and country, rather than relying on a single “semaglutide patent expiry” date. DrugPatentWatch is designed for that multi-patent view [1].
Where can I check the exact expiry dates for a specific country/product?
Use DrugPatentWatch’s semaglutide patent listings to identify the specific patent(s) and their expiry dates for the product/form you care about (injectable vs. oral, and the target country) [1].
Sources
[1] https://www.drugpatentwatch.com/patent/semaglutide